Enhancing Immunotherapy: The Race to Make "Cold" Tumors "Hot"

A growing arsenal of new drugs that unleash the body’s immune system against tumors has captured the cancer treatment spotlight.

Metastatic Breast Cancer Survivor Thriving on Clinical Trial

Sharon DeCosta’s stage IV metastatic breast cancer has been stabilized for three years, allowing her a full life of traveling and doting on her three young grandchildren, with a fourth due in December.

Stage IV Lung Cancer Patient in Remission for Years After Immunotherapy

July 3, 2018

Nancy Hale was given a 30 percent chance of surviving three years when she was diagnosed with lung cancer. But today, six years after her initial diagnosis and because of an immunotherapy clinical trial, Hale is in remission—and “blazing the trail” for other patients.

Nancy Hale.

Stay in touch with us

Sign up to subscribe to any of our e-newsletters or digital content.